Browsing Tag
Cooley
2 posts
Why OpenAI’s growing legal bench signals the next phase of AI power politics
OpenAI’s Big Law buildout shows AI’s next battle is legal, financial and regulatory. See why lawsuits may shape the sector’s future.
Lilly bets up to $2.3bn on Ajax Therapeutics to crack the resistant myelofibrosis market with a Type II JAK2 inhibitor
Lilly is paying up to $2.3B for Ajax Therapeutics' Type II JAK2 inhibitor. The real question is whether it can crack Incyte's Jakafi grip on myelofibrosis.